Mednax Inc (MD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published : Nov-2017

No. of Pages : 89

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Mednax Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Mednax Inc, Medical Devices Deals, 2011 to YTD 2017 10
Mednax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mednax Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Mednax Acquires Northern Westchester Anesthesia Services 14
Mednax Acquires Neonatology Practice In Texas 15
Mednax Acquires Neonatal Intensive Care Associates 16
Mednax Acquires Anesthesia Group of Onondaga, Anesthesiology Group Practice 17
Mednax Acquires Anesthesia Specialists of Houston, Anesthesiology Group Practice 18
Mednax Acquires Gwinnett Anesthesia Service, Anesthesiology Group Practice 19
Mednax Acquires Anesthesiologists Associated, Anesthesiology Group Practice 20
Mednax Acquires South Oakland Anesthesia Associates, Anesthesiology Group Practice 21
Mednax Acquires Maternal-Fetal Medicine Physician Practice In Georgia 22
Mednax Acquires DeKalb Anesthesia Associates, Anesthesiology Group Practice 23
Mednax Acquires Pediatric Hospitalist Group In Florida 24
Mednax Acquires Pediatric Cardiology of Austin 25
Mednax Acquires Anesthesia Medical Alliance of East Tennessee 26
Mednax Acquires Loudoun Anesthesia Associates, Healthcare Services Provider 27
MEDNAX Acquires Burlington Anesthesia And Farhouch Berdjis MD Medical 28
MEDNAX Acquires Three Physician Practices From Children's Specialists Medical Group 29
MEDNAX Acquires Bexar Pediatric Surgery Associates 30
MEDNAX Acquires Midwest Maternal-Fetal Medicine 31
MEDNAX Acquires Hill Country Maternal Fetal Medicine 32
MEDNAX Acquires Miami Based Pediatric Cardiology Practitioner 33
MEDNAX Acquires Good Night Pediatrics 34
MEDNAX Acquires Center For Maternal Fetal Care 35
Acquisition 36
Mednax Acquires Millennium Anesthesia Care 36
Mednax Acquires Lakeshore Anesthesia Services 37
Mednax Acquires Manassas Anesthesia Associates 38
Mednax Acquires Natchez Trace Neonatology 39
Mednax Acquires Commonwealth Neonatology 40
Mednax Acquires Mosaic Anesthesia 41
Mednax Acquires Houston Perinatal Associates 42
Mednax Acquires Associated Anesthesiologists of Joliet 43
Mednax Acquires Anesthesia & Pain Management Group 44
Mednax Acquires Cross River Anesthesiologist Services 45
Mednax Acquires Fredericksburg Anesthesia Associates 46
Mednax Acquires Piedmont Neonatology, Neonatal Care Practice 47
Mednax Acquires Great Lakes Anesthesia Associates, Anesthesiology Practice 48
Mednax Acquires Physicians Anesthesia Associates, Anesthesiology Practice 49
Mednax Acquires Summit Anesthesia Associates 50
Mednax Acquires Neonatology Center Of Winchester 51
Mednax Acquires Dayton Newborn Care Specialists, Neonatal Care Practice 52
Mednax Acquires Holston Anesthesia Associates, Healthcare Services Provider 53
Mednax Acquires Neonatology Associates, Neonatal Physician Group 54
Mednax Acquires Pediatric Surgical And Associates, Healthcare Services Provider 55
Mednax Acquires Florida Atlantic Anesthesia, Provider Of Anesthesia Services 56
American Anesthesiology Acquires Brazos Anesthesiology Associates 57
American Anesthesiology Acquires Burlington Anesthesia Associates 58
American Anesthesiology Acquires Austin Anesthesiology Group 59
MEDNAX Acquires Northwest Newborn Specialists 60
American Anesthesiology Acquires Pinnacle Anesthesia 61
Mednax Inc - Key Competitors 62
Mednax Inc - Key Employees 63
Mednax Inc - Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Recent Developments 68
Financial Announcements 68
Nov 01, 2017: MEDNAX Reports Third Quarter GAAP EPS of $0.71; Adjusted EPS of $0.87 68
Jul 28, 2017: MEDNAX Reports Second Quarter GAAP EPS of $0.69 71
May 04, 2017: MEDNAX Reports First Quarter GAAP EPS of $0.59; Adjusted EPS of $0.75 73
Apr 20, 2017: MEDNAX Previews 2017 First Quarter Results 75
Feb 07, 2017: MEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00 77
Oct 27, 2016: MEDNAX Reports Third Quarter GAAP EPS of $1.04; Adjusted EPS of $1.09 79
Jul 28, 2016: MEDNAX Reports Second Quarter GAAP EPS of $0.89; Adjusted EPS of $1.03 81
Apr 28, 2016: MEDNAX Reports First Quarter Adjusted EPS of $0.87; GAAP EPS of $0.73 83
Feb 04, 2016: MEDNAX Reports Double-Digit Fourth Quarter 2015 Revenue and EPS Growth 85
Corporate Communications 87
Nov 07, 2016: MEDNAX Announces Divisional Leadership Changes 87
Other Significant Developments 88
Jul 12, 2016: MEDNAX to Exhibit at the 24th Annual Health Forum and the American Hospital Association Leadership Summit 88
Appendix 89
Methodology 89
About GlobalData 89
Contact Us 89
Disclaimer 89

List of Tables
Mednax Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Mednax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Mednax Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Mednax Inc, Medical Devices Deals, 2011 to YTD 2017 10
Mednax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mednax Acquires Northern Westchester Anesthesia Services 14
Mednax Acquires Neonatology Practice In Texas 15
Mednax Acquires Neonatal Intensive Care Associates 16
Mednax Acquires Anesthesia Group of Onondaga, Anesthesiology Group Practice 17
Mednax Acquires Anesthesia Specialists of Houston, Anesthesiology Group Practice 18
Mednax Acquires Gwinnett Anesthesia Service, Anesthesiology Group Practice 19
Mednax Acquires Anesthesiologists Associated, Anesthesiology Group Practice 20
Mednax Acquires South Oakland Anesthesia Associates, Anesthesiology Group Practice 21
Mednax Acquires Maternal-Fetal Medicine Physician Practice In Georgia 22
Mednax Acquires DeKalb Anesthesia Associates, Anesthesiology Group Practice 23
Mednax Acquires Pediatric Hospitalist Group In Florida 24
Mednax Acquires Pediatric Cardiology of Austin 25
Mednax Acquires Anesthesia Medical Alliance of East Tennessee 26
Mednax Acquires Loudoun Anesthesia Associates, Healthcare Services Provider 27
MEDNAX Acquires Burlington Anesthesia And Farhouch Berdjis MD Medical 28
MEDNAX Acquires Three Physician Practices From Children's Specialists Medical Group 29
MEDNAX Acquires Bexar Pediatric Surgery Associates 30
MEDNAX Acquires Midwest Maternal-Fetal Medicine 31
MEDNAX Acquires Hill Country Maternal Fetal Medicine 32
MEDNAX Acquires Miami Based Pediatric Cardiology Practitioner 33
MEDNAX Acquires Good Night Pediatrics 34
MEDNAX Acquires Center For Maternal Fetal Care 35
Mednax Acquires Millennium Anesthesia Care 36
Mednax Acquires Lakeshore Anesthesia Services 37
Mednax Acquires Manassas Anesthesia Associates 38
Mednax Acquires Natchez Trace Neonatology 39
Mednax Acquires Commonwealth Neonatology 40
Mednax Acquires Mosaic Anesthesia 41
Mednax Acquires Houston Perinatal Associates 42
Mednax Acquires Associated Anesthesiologists of Joliet 43
Mednax Acquires Anesthesia & Pain Management Group 44
Mednax Acquires Cross River Anesthesiologist Services 45
Mednax Acquires Fredericksburg Anesthesia Associates 46
Mednax Acquires Piedmont Neonatology, Neonatal Care Practice 47
Mednax Acquires Great Lakes Anesthesia Associates, Anesthesiology Practice 48
Mednax Acquires Physicians Anesthesia Associates, Anesthesiology Practice 49
Mednax Acquires Summit Anesthesia Associates 50
Mednax Acquires Neonatology Center Of Winchester 51
Mednax Acquires Dayton Newborn Care Specialists, Neonatal Care Practice 52
Mednax Acquires Holston Anesthesia Associates, Healthcare Services Provider 53
Mednax Acquires Neonatology Associates, Neonatal Physician Group 54
Mednax Acquires Pediatric Surgical And Associates, Healthcare Services Provider 55
Mednax Acquires Florida Atlantic Anesthesia, Provider Of Anesthesia Services 56
American Anesthesiology Acquires Brazos Anesthesiology Associates 57
American Anesthesiology Acquires Burlington Anesthesia Associates 58
American Anesthesiology Acquires Austin Anesthesiology Group 59
MEDNAX Acquires Northwest Newborn Specialists 60
American Anesthesiology Acquires Pinnacle Anesthesia 61
Mednax Inc, Key Competitors 62
Mednax Inc, Key Employees 63
Mednax Inc, Subsidiaries 65

List of Figures
Mednax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Mednax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
Mednax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Mednax Inc, Medical Devices Deals, 2011 to YTD 2017 10

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Mednax Inc (MD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027